new-peak
111

111.com.cn

Digital & Ecommerce

Location: China

Year of Investment: 2014

Investment Status: Active

Verlinvest contact: Raphael Thiolon

Visit Website

Overview

Founded by Junling Liu and Gang Yu, one of the most talented e-commerce teams in China who were also behind the success of multi-billion online grocery business Yihaodian (which they sold to Walmart, now part of JD.com), New Peak aims to become China’s leading and most trusted online pharmacy and healthcare platform.

The company, positioned at the crossroads of the booming Chinese healthcare and e-commerce markets, is primarily focusing on the growth of its direct B2C online drug store, 111.com.cn, which sells both drugs (OTC and prescribed medicine) and a large range of health-related products (lenses, vitamins, supplements, medical equipment, etc.). In addition, New Peak is building B2B online platforms to allow hospitals and pharmacies to directly buy medicines from pharma manufacturers, and therefore reduce the number of intermediaries in China’s drug-sourcing chain.

New Peak is also engaged in the development of an innovative consumer health service portal named Yizhen, which offers remote doctor diagnosis together with extensive drug and medicine information / recommendations.

The founders’ ultimate vision is to enable hundreds of millions of Chinese consumers to get access to higher-quality and more reliable medical services, including more affordable drugs. Verlinvest first invested in the business in December 2014.

Find us
Brussels

Place Eugène Flagey 18
B-1050 Brussels

Singapore

Verlinvest Asia Pte Ltd.
163 Penang Road, Winsland House 2,
#04-04
Singapore 238463

New York

Suite 2005,
215 Park Avenue South,
New York, NY 10003

London

4th Floor,
21 Ganton Street,
London,
W1F 9BW

Mumbai

Verlinvest India Investment Advisor Private Limited
Floor 2, WeWork Enam Sambhav
C - 20, G Block, Bandra Kurla Complex
Mumbai, Maharashtra 400051

Get in touch
© Verlinvest 2022